MedPath

A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

Phase 2
Completed
Conditions
HIV Infections
Cancer
Pain
Registration Number
NCT00002160
Lead Sponsor
Neurex
Brief Summary

To determine the safety and efficacy of SNX-111 in controlling severe, chronic pain in cancer and AIDS patients.

Detailed Description

Patients are randomized to receive SNX-111 or placebo (AS PER AMENDMENT 1/22/98: with randomization weighted 2:1 in favor of SNX-111) via external pump and an intrathecal catheter (thin tube inserted into the spinal canal). (AS PER AMENDMENT 1/22/98: the dose is increased every 24 hours, in the absence of onset of analgesia or adverse events. After 2-5 days, patients who respond to their medication continue treatment at home for 5-8 days. Patients who do not respond will be switched to the other regimen (i.e., placebo to SNX-111, or SNX-111 to placebo). After 10 days, responding patients are unblinded and asked to enroll in the long-term, open-label extension protocol. Patients remain on a fixed dose at the therapeutic level found in the previous study. The dose may be increased or decreased at the discretion of the investigator. Patients may continue therapy on a long-term basis until the drug is approved.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (44)

Ctr for Pain Management and Rehabilitation

🇺🇸

Huntsville, Alabama, United States

Gulf Coast Clinical Services

🇺🇸

Mobile, Alabama, United States

Northport Hosp

🇺🇸

Northport, Alabama, United States

Holt Krock Clinic

🇺🇸

Fort Smith, Arkansas, United States

Alta Bates Hosp

🇺🇸

Berkeley, California, United States

Pain Diagnosis and Treatment

🇺🇸

Glendora, California, United States

Univ of CA - San Diego

🇺🇸

San Diego, California, United States

Good Samaritan Hosp Ctr

🇺🇸

San Jose, California, United States

Connecticut Pain Care

🇺🇸

Danbury, Connecticut, United States

VA Med Ctr / Oncology Section

🇺🇸

Washington, District of Columbia, United States

Scroll for more (34 remaining)
Ctr for Pain Management and Rehabilitation
🇺🇸Huntsville, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.